Subesh Williams
Director/Board Member chez GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Profil
Subesh Ronald Williams is currently a Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd.
and a Director at Galvani Bioelectronics Ltd.
Previously, he worked as a Senior Vice President-Corporate Development at GSK Plc, a Manager at PricewaterhouseCoopers Pvt Ltd., and as the Chief Financial Officer at ViiV.
Healthcare BV from 2009 to 2013.
Postes actifs de Subesh Williams
| Sociétés | Poste | Début |
|---|---|---|
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Director/Board Member | 07/04/2017 |
Galvani Bioelectronics Ltd.
 Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The private company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | Director/Board Member | 16/11/2016 |
Anciens postes connus de Subesh Williams
| Sociétés | Poste | Fin |
|---|---|---|
ViiV Healthcare BV
 ViiV Healthcare BV Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare BV is a Dutch company that manufactures and distributes pharmaceutical products. The private company is based in Amersfoort, Netherlands. | Director of Finance/CFO | 01/01/2013 |
PricewaterhouseCoopers Pvt Ltd.
 PricewaterhouseCoopers Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Pvt Ltd. provides accounting services. It offers services such as consulting, deals, risk advisory services, forensic services, accounting advisory, tax, and regulatory services. The company was incorporated on March 26, 1983 and is headquartered in Gurgaon, India. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
PricewaterhouseCoopers Pvt Ltd.
PricewaterhouseCoopers Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Pvt Ltd. provides accounting services. It offers services such as consulting, deals, risk advisory services, forensic services, accounting advisory, tax, and regulatory services. The company was incorporated on March 26, 1983 and is headquartered in Gurgaon, India. | Commercial Services |
ViiV Healthcare BV
ViiV Healthcare BV Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare BV is a Dutch company that manufactures and distributes pharmaceutical products. The private company is based in Amersfoort, Netherlands. | Health Technology |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The private company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | Health Technology |
